incentives

Biotech By Jonathan Wosen

Roche looks to compete against a blockbuster with its newly approved vision drug

Health By Andrew Joseph

Early data indicate vaccines still protect against Omicron’s sister variant, BA.2

Pharmalot By Ed Silverman

Up and down the ladder: the latest comings and goings

Pharmalot By Damian Garde

Pharmalittle: Biogen sells stake in biosimilars business for $2.3 billion; Lilly gives up on a lucrative idea

First Opinion By Jennifer Goldsack and Soujanya (Chinni) Pulluru

Break the stranglehold of the doctor-patient visit on health care innovation

First Opinion By Vincent Casingal

Maximizing kidney transplant equity means minimizing geography

The Readout LOUD By Adam Feuerstein, Damian Garde and Meg Tirrell

‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines

Health By Elizabeth Cooney

In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog